Abstract
Both the renin-angiotensin-aldosterone system (RAAS) and hypoxia are vital physiological factors involved in the control of nephrogenesis and vascularization. We investigated the relationship between RAAS and hypoxia in the developing kidney. The expression of VEGF and heme oxygenase (HO)-1 related with the oxygen was analyzed in the enalapril- or spironolactone-treated neonatal rat kidneys. Enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) was administered to newborn rat pups for 7 d. The newborn rats were injected i.p. with pimonidazole (200 mg/kg), a marker of severe tissue hypoxia, 1 h before killing. VEGF and HO-1 protein expression was significantly increased by immunoblots and immunohistochemistry in both the enalapril- and spironolactone-treated kidneys, compared with the controls (p < 0.05). HO-1 mRNA expression was increased in the spironolactone-treated group (p < 0.05). The immunoactivity of pimonidazole was not different from that of the controls in the enalapril-treated group, whereas it was increased in the spironolactone-treated group. The results of this study indicate that aldosterone blockade or angiotensin II inhibition in the developing rat kidney up-regulated renal VEGF and HO-1 expression regardless of the hypoxic conditions and may differentially modulate VEGF and HO-1 production.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ACE:
-
angiotensin-converting enzyme
- Aldo:
-
aldosterone
- Ang:
-
angiotensin
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- HIF:
-
hypoxia-inducible factor
- HO:
-
heme oxygenase
- RAAS:
-
renin-angiotensin-aldosterone system
REFERENCES
Hilgers KF, Norwood VF, Gomez RA 1997 Angiotensin's role in renal development. Semin Nephrol 17: 492–501
Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA 1995 Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269: F110–F115
Bernhardt WM, Schmitt R, Rosenberger C, Münchenhagen PM, Gröne HJ, Frei U, Warnecke C, Bachmann S, Wiesener MS, Willam C, Eckardt KU 2006 Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int 69: 114–122
Freeburg PB, Robert B, St John PL, Abrahamson DR 2003 Podocyte expression of hypoxia inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14: 927–938
Wakelin SJ, Marson L, Howie SE, Garden J, Lamb JR, Forsythe JL 2004 The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol 98: 73–79
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435–439
Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL 1998 VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17: 303–311
Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH, Lee MH, Song HK, Cha DR, Kang SW, Han DS 2006 Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 36: 377–388
Feliers D, Gorin Y, Ghosh-Choudhury G, Abboud HE, Kasinath BS 2006 Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol 290: F927–F936
Lai L, Pen A, Hu Y, Ma J, Chen J, Hao CM, Gu Y, Lin S 2007 Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor. Life Sci 81: 570–576
Dulak J, Loboda A, Zagorska A, Jozkowicz A 2004 Complex role of heme oxygenase-1 in angiogenesis. Antioxid Redox Signal 6: 858–866
Ryter SW, Otterbein LE, Morse D, Choi AM 2002 Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235: 249–263
Maines MD 1997 The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517–554
Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, Abraham NG 2005 Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 68: 2745–2755
Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG 2005 D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing and improves vascular reactivity in a rat model of diabetes. Circulation 111: 3126–3134
Yim HE, Kim JH, Yoo KH, Bae IS, Jang GY, Hong YS, Lee JW 2010 Spironolactone, but not enalapril, potentiates hypoxia-inducible factor-1alpha and Ets-1 expression in newborn rat kidney. J Physiol Pharmacol 61: 73–81
Richard DE, Berra E, Pouyssegur J 2000 Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765–26771
Schofield CJ, Ratcliffe PJ 2004 Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343–354
Tso JY, Sun XH, Kao TH, Reece KS, Wu R 1985 Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485–2502
Bortolini MA, Silva ID, Hamerski MG, Castro RA, Sartori MG, Girao MJ 2007 Influence of ovarian hormones deprivation on gene expression in the lower urinary tract of rats. Int Braz J Urol 33: 544–552
Wang HH, Zhou HY, Chen CC, Zhang XL, Cheng G 2007 Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacol Sin 28: 1175–1180
Yang ZZ, Zou AP 2001 Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells. Am J Physiol Renal Physiol 281: F900–F908
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604–4613
Fernandez M, Bonkovsky HL 2003 Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634–640
Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL 2004 Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin–angiotension system. Am J Hypertens 17: 597–603
Ndisang JF, Lane N, Jadhav A 2008 Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 26: 1188–1199
Yim HE, Yoo KH, Bae IS, Jang GY, Hong YS, Lee JW 2009 Aldosterone regulates cellular turnover and mitogen-activated protein kinase family expression in the neonatal rat kidney. J Cell Physiol 219: 724–733
Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ 1998 Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339: 1285–1292
Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS 2005 Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 25: 65–70
Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T 2008 Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension 51: 252–258
Dulak J, Józkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, Motterlini R 2002 Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229–240
Choi BM, Yoo KH, Bae IS, Oh MH, Hong YS, Lee JW, Kim SK 2005 Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 57: 115–123
Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A, Yoshizumi M 2005 Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 46: 1046–1052
Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A 2005 Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46: 1039–1045
Rüster C, Wolf G 2006 Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17: 2985–2991
Chen Y, Lasaitiene D, Friberg P 2004 The renin-angiotensin system in kidney development. Acta Physiol Scand 181: 529–535
Guron G, Nilsson A, Nitescu N, Nielsen S, Sundelin B, Frøkiaer J, Friberg P 1999 Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril. Acta Physiol Scand 165: 103–112
Nilsson AB, Friberg P 2000 Acute renal responses to angiotensin-converting enzyme inhibition in the neonatal pig. Pediatr Nephrol 14: 1071–1076
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yim, H., Kim, J., Yoo, K. et al. Spironolactone and Enalapril Differentially Up-Regulate the Expression of VEGF and Heme Oxygenase-1 in the Neonatal Rat Kidney. Pediatr Res 69, 378–383 (2011). https://doi.org/10.1203/PDR.0b013e3182114c38
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3182114c38
